It is impossible to say exactly how proton beam therapy will progress over the next decade but the indications are, it will become more widely used.
The number of centres available to provide proton beam therapy is expected to double between 2012 and 2021, giving more patients access to treatment.
One of the big controversies about proton beam therapy is the cost. It is usual for a medical centre to spend over £100 million to develop a proton beam therapy facility, yet an intensity modulated radiotherapy system usually costs around £4 million.
The running costs for a proton beam therapy facility are higher too, so individual treatments cost 2-3 times as much as intensity modulated radiotherapy.
Until the evidence shows that proton beam therapy is more effective than radiotherapy based on X-rays, some doctors think that spending more money on more centres is not a good use of resources.
However, more evidence is emerging that PBT is effective and with a lower risk of long-term side effects. The key to the future of proton beam therapy seems to be balance: national governments need to ensure that enough facilities are built to treat people to save the cost of funding travel outside the country but that centres collaborate so that very expensive PBT equipment is not lying idle because of too few patients.
These are just some of the centres that are currently being built and developed:
There is general agreement that more clinical trials are necessary to compare the efficacy of proton beam therapy directly with that of standard radiotherapy for specific cancers.
The trouble is, these clinical trials would take years to run, as the real advantage of proton beam therapy is in the lowered risk of side effects. It would take several years to assess whether patients treated with PBT were less likely to develop radiotherapy-related cancers later in life, or to have other problems.
It is important to study the impact of proton beam therapy but denying patients treatment would be unethical. Clinical trials are ongoing throughout the world and new indications for proton beam therapy are being actively researched. Patients with cancers that are not usually treated by proton beam therapy can be entered into a clinical trial so that the impact of the treatment can be assessed.
The King Hussein Cancer Centre treats all cancers and performs approximately 300 bone marrow transplants a year. The King Hussein Cancer Centre is the one of the only specialised cancer centres in the Middle East treating both adults and children. They also offer various diagnostic imaging services such as MRI and CT scans and have a highly advanced Chemotherapy Unit.